MEDICAL cannabis company Kanabo Group has appointed Dr Dan Poulter MP as a Non-Executive Director to the board.
Dr Poulter, a former UK Government health minister, and chairperson of the All-Party Parliamentary Group for Global Health, has in-depth knowledge of the drugs and medicines regulatory framework in the UK.
A practicing NHS Psychiatrist, he believes that prescribed cannabis products could bring considerable health benefits to help people experiencing mental ill health and distress.
Dr Poulter said: “As a doctor, I am increasingly aware of the potential of cannabis-based medicines. Cannabis products are fast becoming available that could deliver significant improvements to the lives of thousands of patients suffering from conditions ranging from chronic pain to post traumatic stress disorder.”
Avihu Tamir, CEO, Kanabo Group, said: “We are delighted to welcome Dr Dan Poulter, MP as a Non-Executive Director to our board. Dan brings a wealth of knowledge and insight into the business that strengthens our team as we build a medicinal cannabis market in the UK and Europe.”
Chairman of the Board, David Tsur, added: “We are delighted that Dr Dan Poulter has joined us and we’d like to warmly welcome him. He brings a wealth of experience and I’m sure will be a very valuable addition to the board. It’s an exciting period for Kanabo to execute the company’s business plan and to expand its activity and strategic partnerships.”
